Reaction profile

The FDA adverse-event record for pr-meninges, lesion(s)

22 FDA reports name pr-meninges, lesion(s), a lower-volume reaction in the CVM extract (VeDDRA 99635). Plate stamps and neighbourhood peers follow.

#2134 of 2,481
by report volume (all reactions)
22
reports citing this reaction
100.0%
death-coded share
Dog
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. PR-MENINGES, LESION(S) has 22 reports now versus 22 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to PR-MENINGES, LESION(S) changes

FDA AER · VeDDRA plate

Code 99635 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 22 reports
  • DEATH-HOT 100.0%
  • LOWER-Q #2134/2481
  • PHOTO-FINISH Adenocarcinoma NOS
  • SPECIES-DOG Dog · 11
  • DRUG-LEAD Cefovecin · 4
  • DESK-WIDE 17 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Adenocarcinoma NOS (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around PR-MENINGES, LESION

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Adenocarcinoma NOS · near22Bolus, Abnormal · near22Bone marrow aplasia · near22CEREBROSPINAL FLUID A… · near22PR-MENINGES, LESION(S) · thi…22Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around PR-MENINGES, LESION(S)

PR-MENINGES, LESION(S): high death-coded share in the FDA AER plate

Signature read: PR-MENINGES, LESION(S)'s 100.0% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 22 named reports in the openFDA extract. Death-coded share is upper-third: 22 of 22 reports (100.0% of named reports). Nearest volume peer: Adenocarcinoma NOS (±0 reports). Lead species Dog (11). Lead co-reported drug Cefovecin (4).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 11
Cat 5
Cattle 4
Ferret 1
Pig 1

Breeds Most Affected

Retriever - Labrador 2
Domestic (unspecified) 2
Lhasa Apso 2
Domestic Shorthair 2
Terrier - Bull - American Pit 2
Cattle (other) 1
Shih Tzu 1
Dachshund (unspecified) 1
Holstein-Friesian also known as Holstein 1
Beagle 1

Associated Drugs

Cefovecin 4
Carprofen 3
Imidacloprid + Moxidectin 3
Diazepam 3
Maropitant 2
Cefovecin Sodium 2
Acepromazine Maleate 2
Sevoflurane 2
Maropitant Citrate 2
Phenobarbital 2
Nitenpyram 1
Tylosin 1
Buprenorphine Hcl 1
Prednisone 1
Florfenicol, Flunixin 1
Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate) 1
Cefazolin 1
Butorphanol 1
Propofol 1
Tramadol 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for PR-MENINGES, LESION(S) (#2134 of 2,481 by report volume); death-coded 100.0%. PlainBreed reaction plate · death-coded share stamp 100.0% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →